European Union regulation of agri-biotechnology: precautionary links between science, expertise and policy

Les Levidow, Susan Carr and David Wield

Science and Public Policy, 2005, vol. 32, issue 4, 261-276

Abstract: Despite various institutional reforms in the European Union (EU), regulatory procedures for genetically modified (GM) products are still held up by disagreements among experts; claims about a product's safety often correspond to a narrower account of precaution than broader counter-claims from objectors. In the EU, we argue, these conflicts have given practical meaning to the concept of precaution, rather than any explicit interpretation of an a priori principle. Through dynamic tensions between the various claims and accounts of precaution, EU regulatory-expert procedures have identified and addressed more scientific uncertainties than before. Yet decisions about GM products still face legitimacy problems, because they arise fundamentally from the great burden placed on science as the basis for societal choices about agri-biotechnology. Copyright , Beech Tree Publishing.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://hdl.handle.net/10.3152/147154305781779452 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:32:y:2005:i:4:p:261-276

Access Statistics for this article

Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas

More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().